Condition
Staphylococcus
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04625478Completed
Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections
NCT04946500Unknown
Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)
NCT02967432Phase 2CompletedPrimary
Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU
NCT01875263Phase 3TerminatedPrimary
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
Showing all 4 trials